Norbornanes
Vasoconstriction
Phenylephrine
Angiotensin II
Norepinephrine
Vascular Resistance
Endothelins
Endothelin-1
Mesenteric Arteries
Sympathetic Nervous System
Vasomotor System
Receptors, Endothelin
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid
Vasodilation
Receptor, Endothelin A
Tyramine
Nitric Oxide
Thromboxane A2
Receptor, Endothelin B
Arterioles
Endothelium, Vascular
Hemodynamics
Dose-Response Relationship, Drug
Prostaglandin Endoperoxides, Synthetic
Urotensins
NG-Nitroarginine Methyl Ester
Potassium Chloride
Indomethacin
Rats, Sprague-Dawley
Receptors, Thromboxane
Nitroprusside
Dogs
Splanchnic Circulation
Serotonin
Muscle Tonus
Hydroxyeicosatetraenoic Acids
Nitric Oxide Synthase
Prostaglandins
Acetylcholine
Viper Venoms
Peptides, Cyclic
Adrenergic alpha-Antagonists
Sumatriptan
Rats, Wistar
Arginine Vasopressin
Adrenergic alpha-1 Receptor Agonists
Laser-Doppler Flowmetry
Blood Vessels
Phentolamine
Enzyme Inhibitors
Kidney
Astringents
Bretylium Compounds
Sympathetic Fibers, Postganglionic
Nitroarginine
Nitric oxide limits the eicosanoid-dependent bronchoconstriction and hypotension induced by endothelin-1 in the guinea-pig. (1/3794)
1. This study attempts to investigate if endogenous nitric oxide (NO) can modulate the eicosanoid-releasing properties of intravenously administered endothelin-1 (ET-1) in the pulmonary and circulatory systems in the guinea-pig. 2. The nitric oxide synthase blocker N(omega)-nitro-L-arginine methyl ester (L-NAME; 300 microM; 30 min infusion) potentiated, in an L-arginine sensitive fashion, the release of thromboxane A2 (TxA2) stimulated by ET-1, the selective ET(B) receptor agonist IRL 1620 (Suc-[Glu9,Ala11,15]-ET-1(8-21)) or bradykinin (BK) (5, 50 and 50 nM, respectively, 3 min infusion) in guinea-pig isolated and perfused lungs. 3. In anaesthetized and ventilated guinea-pigs intravenous injection of ET-1 (0.1-1.0 nmol kg(-1)), IRL 1620 (0.2-1.6 nmol kg(-1)), BK (1.0-10.0 nmol kg(-1)) or U 46619 (0.2-5.7 nmol kg(-1)) each induced dose-dependent increases in pulmonary insufflation pressure (PIP). Pretreatment with L-NAME (5 mg kg(-1)) did not change basal PIP, but increased, in L-arginine sensitive manner, the magnitude of the PIP increases (in both amplitude and duration) triggered by each of the peptides (at 0.25, 0.4 and 1.0 nmol kg(-1), respectively), without modifying bronchoconstriction caused by U 46619 (0.57 nmol kg(-1)). 4. The increases in PIP induced by ET-1, IRL 1620 (0.25 and 0.4 nmol kg(-1), respectively) or U 46619 (0.57 nmol kg(-1)) were accompanied by rapid and transient increases of mean arterial blood pressure (MAP). Pretreatment with L-NAME (5 mg kg(-1); i.v. raised basal MAP persistently and, under this condition, subsequent administration of ET-1 or IRL 1620, but not of U-46619, induced hypotensive responses which were prevented by pretreatment with the cyclo-oxygenase inhibitor indomethacin. 5. Thus, endogenous NO appears to modulate ET-1-induced bronchoconstriction and pressor effects in the guinea-pig by limiting the peptide's ability to induce, possibly via ET(B) receptors, the release of TxA2 in the lungs and of vasodilatory prostanoids in the systemic circulation. Furthermore, it would seem that these eicosanoid-dependent actions of ET-1 in the pulmonary system and on systemic arterial resistance in this species are physiologically dissociated. (+info)Effect of acute and long-term treatment with 17-beta-estradiol on the vasomotor responses in the rat aorta. (2/3794)
1. This study sought to evaluate whether the effects of acute and long-term treatment with 17-beta-estradiol on the vasomotor responses in rat aortic rings are mediated through the same mechanism. 2. Ovariectomized rats were treated daily with either 17-beta-estradiol-3-benzoate (100 microg kg(-1)) or vehicle for 1 week. 3. The effect of long-term 17-beta-estradiol treatment on the responses to cumulative doses of phenylephrine, 5-HT, calcium, potassium and 17-beta-estradiol was determined in aortic rings. In the same rings, the effect of acute exposure to 17-beta-estradiol (5 and 10 microM) on the dose response curves for phenylephrine, 5-HT, calcium, potassium and acetylcholine were estimated. The measurements were made in rings with and without intact endothelium. The tone-related basal release of nitric oxide (NO) was measured in rings with intact endothelium. 4. Long-term 17-beta-estradiol treatment reduced the maximum developed contraction to all contracting agents studied. This effect was abolished in endothelium denuded vessels. Acute 17-beta-estradiol treatment also reduced maximal contraction. This effect, however, was independent of the endothelium. 5. Long-term 17-beta-estradiol treatment significantly increased the ability of the rings to dilate in response to acetylcholine whereas acute exposure to 17-beta-estradiol had no effect. The tone-related release of NO was significantly increased after long-term exposure to 17-beta-estradiol. 6. In conclusion, this study indicate that the acute and long-term effects of 17-beta-estradiol in the rat aorta are mediated through different mechanisms. The long-term effect is mediated through the endothelium most likely by increasing NO release. In contrast, the acute effect of 17-beta-estradiol seems to be through an effect on the vascular smooth muscle cells. (+info)Anaphylactic bronchoconstriction in BP2 mice: interactions between serotonin and acetylcholine. (3/3794)
1. Immunized BP2 mice developed an acute bronchoconstriction in vivo and airway muscle contraction in vitro in response to ovalbumin (OA) and these contractions were dose dependent. 2. Methysergide or atropine inhibited OA-induced bronchoconstriction in vivo and airway muscle contraction in vitro. 3. Neostigmine potentiated the OA-induced bronchoconstriction in vivo and airway muscle contraction in vitro of BP2 mice. This potentiation was markedly reduced by the administration of methysergide or atropine and when the two antagonists were administered together, the responses were completely inhibited. 4. Neostigmine also potentiated the serotonin (5-HT)- and acetylcholine (ACh)-induced bronchoconstriction and this potentiation was significantly reversed by atropine. 5. These results indicate that OA provokes a bronchoconstriction in immunized BP2 mice by stimulating the release of 5-HT, which in turn acts via the cholinergic mediator, ACh. (+info)Modulation of temperature-induced tone by vasoconstrictor agents. (4/3794)
One of the primary cardiovascular adjustments to hyperthermia is a sympathetically mediated increase in vascular resistance in the viscera. Nonneural factors such as a change in vascular tone or reactivity may also contribute to this response. Therefore, the aim of this study was to determine whether vascular smooth muscle tone is altered during heating to physiologically relevant temperatures >37 degrees C. Gradually increasing bath temperature from 37 degrees C (normothermia) to 43 degrees C (severe hyperthermia) produced graded contractions in vascular ring segments from rat mesenteric arteries and thoracic aortae. In untreated rings these contractions were relatively small, whereas hyperthermia elicited near-maximal increases in tension when rings were constricted with phenylephrine or KCl before heating. In phenylephrine-treated mesenteric arterial rings, the contractile responses to heating were markedly attenuated by the Ca2+ channel antagonists nifedipine and diltiazem. Diltiazem also blocked the contractile responses to heating in thoracic aortic rings. These results demonstrate that hyperthermia has a limited effect on tension generation in rat vascular smooth muscle in the absence of vascular tone. However, in the presence of agonist-induced tone, tension generation during heating is markedly enhanced and dependent on extracellular Ca2+. In conclusion, these data suggest that local regulation of vascular tone can contribute to the hemodynamic adjustments to hyperthermia. (+info)Spread of vasodilatation and vasoconstriction along feed arteries and arterioles of hamster skeletal muscle. (5/3794)
1. In arterioles of the hamster cheek pouch, vasodilatation and vasoconstriction can spread via the conduction of electrical signals through gap junctions between cells that comprise the vessel wall. However, conduction in resistance networks supplying other tissues has received relatively little attention. In anaesthetized hamsters, we have investigated the spread of dilatation and constriction along feed arteries and arterioles of the retractor muscle, which is contiguous with the cheek pouch. 2. When released from a micropipette, acetylcholine (ACh) triggered vasodilatation that spread rapidly along feed arteries external to the muscle and arterioles within the muscle. Responses were independent of changes in wall shear rate, perivascular nerve activity, or release of nitric oxide, indicating cell-to-cell conduction. 3. Vasodilatation conducted without decrement along unbranched feed arteries, yet decayed markedly in arteriolar networks. Thus, branching of the conduction pathway dissipated the vasodilatation. 4. Noradrenaline (NA) or a depolarizing KCl stimulus evoked constriction of arterioles and feed arteries of the retractor muscle that was constrained to the vicinity of the micropipette. This behaviour contrasts sharply with the conduction of vasodilatation in these microvessels and with the conduction of vasoconstriction elicited by NA and KCl in cheek pouch arterioles. 5. Focal electrical stimulation produced constriction that spread rapidly along feed arteries and arterioles. These responses were inhibited by tetrodotoxin or prazosin, confirming the release of NA along perivascular sympathetic nerves, which are absent from arterioles studied in the cheek pouch. Thus, sympathetic nerve activity co-ordinated the contraction of smooth muscle cells as effectively as the conduction of vasodilatation co-ordinated their relaxation. 6. In the light of previous findings in the cheek pouch, the properties of vasoconstriction and vasodilatation in feed arteries and arterioles of the retractor muscle indicate that substantive differences can exist in the nature of signal transmission along microvessels of tissues that differ in structure and function. (+info)Angiotensin II-induced constrictions are masked by bovine retinal vessels. (6/3794)
PURPOSE: To unmask the vasoconstricting effect of angiotensin II (Ang II) on retinal smooth muscle by studying its interaction with endothelium-derived paracrine substances. This study focused specifically on determining the changes in vascular diameter and the release of endothelial-derived vasodilators, nitric oxide (NO) and prostaglandin (PG) I2, from isolated retinal microvessels. METHODS: Bovine retinal central artery and vein were cannulated, and arterioles and venules were perfused with oxygenated/heparinized physiological salt solution at 37 degrees C. This ex vivo perfused retinal microcirculation model was used to observe the contractile effects of Ang II on arterioles and venules of different diameters. The NO and PGI2 synthase inhibitors, 1-NOARG and flurbiprofen, respectively, were used to unmask Ang II vasoconstriction; the changes in vascular diameters were then measured. Enzyme immunoassays were used to measure the release of cGMP (an index of NO release) and 6-keto-PG-F1alpha (a stable metabolite of PGI2) from isolated bovine retinal vessels. RESULTS: Topically applied Ang II (10(-10) M to 10(-4) M) caused significant (P < 0.05) arteriolar and venular constrictions in a dose-dependent manner, with the smallest retinal arterioles (7+/-0.2 microm luminal diameter) and venules (12+/-2 microm luminal diameter) significantly more sensitive than larger vessels. After the inhibition of endogenous NO and PGI2 synthesis by 1-NOARG and flurbiprofen, respectively, the vasoconstriction effects of Ang II became more pronounced. Again, the smallest vessels tested were significantly more sensitive, and synthesis of endothelial-derived relaxing factor (EDRF), therefore, may be most important in these vessels. Vasoactive doses of Ang II (10(-10) M to 10(-4) M) caused a dose-dependent increase in the release of NO and PGI2 from isolated bovine retinal vessels, indicating that the increase in EDRF may nullify direct Ang II-induced vasoconstriction. Interestingly, intraluminal administration of Ang II caused only vasodilation. CONCLUSIONS: This study demonstrates that the retinal vascular endothelium acts as a buffer against the vasoconstricting agent Ang II via release of vasodilators NO and PGI2, and the vasoconstriction effects due to Ang II are most prominent in the smallest diameter vessels. (+info)Epidermal growth factor: a potent vasoconstrictor in experimental hypertension. (7/3794)
We have tested the hypothesis that growth factor signaling pathways are augmented in hypertension, a disease associated with vascular smooth muscle cell growth. Thoracic aorta was dissected from deoxycorticosterone acetate-salt (DOCA-salt) and one kidney, one clip (1K, 1C) hypertensive rats and from sham normotensive rats for use in isolated tissue bath experiments. Systolic blood pressure was significantly higher in DOCA-salt and 1K, 1C than in normotensive sham rats: 192 +/- 7, 185 +/- 10, and 117 +/- 4 mmHg, respectively. Although virtually no contraction to epidermal growth factor (EGF) was observed in endothelium-denuded sham rat aorta [1 +/- 1% phenylephrine (PE) (10 micromol/l)-induced contraction], the maximal EGF-induced contraction was 45 +/- 7% in endothelium-denuded aorta from DOCA-salt hypertensive rats and 39 +/- 7% in aorta from 1K, 1C rats. Although slightly attenuated, a contraction to EGF was still observed in endothelium-intact aortic strips from 28-day DOCA-salt hypertensive rats. We also conducted concentration-response curves to EGF on days 1, 3, 5, 7, 14, and 21 of DOCA-salt therapy. A significant contraction to EGF in aorta from DOCA-salt rats was observed on day 14, when DOCA-salt rats had significantly higher blood pressure than sham rats: 188 +/- 6 and 122 +/- 3 mmHg, respectively. Transforming growth factor-alpha, an agonist of the EGF receptor, contracted DOCA-salt rat aorta (30 +/- 7% PE-induced contraction) but not sham aorta (3 +/- 3%). The EGF receptor tyrosine kinase inhibitor 4,5-dianilinophthalimide (10 micromol/l), the mitogen-activated protein kinase kinase inhibitor PD-098059 (10 micromol/l), and the L-type voltage-gated calcium channel inhibitor diltiazem (1 mol/l), but not the cyclooxygenase inhibitor indomethacin (10 micromol/l), virtually abolished EGF-induced contraction (85, 98, and 99% reduction, respectively). These data support a striking difference in EGF signaling between normotensive and hypertensive animals. Furthermore, they provide evidence that growth factors should be considered vasoconstrictors as well as growth modulators in hypertension. (+info)Norepinephrine stimulates lymphoid cell mobilization from the perfused rat spleen via beta-adrenergic receptors. (8/3794)
The possibility that norepinephrine (NE) influences lymphoid cell outflow independently of its vasoconstrictor action was investigated in the perfused rat spleen. Using agents that affect the vasoconstrictor tonus of the spleen, we observed an inverse correlation between flow resistance and splenic cell output. The curve obtained served as a reference for evaluating effects of different treatments on the number of cells that are mobilized at defined levels of flow resistance. Perfusion of the beta-adrenergic blocker propranolol either alone or in combination with NE lowered splenic leukocyte outflow clearly beyond the number of cells expected at the corresponding flow resistance. No comparable effects were observed when the alpha-adrenergic blocker phentolamine was perfused. When the vasoconstrictor effect of NE was counteracted by papaverine, splenic cell outflow was significantly higher than expected for the level of flow resistance attained. Furthermore, when NE was perfused together with endotoxin, which does not inhibit the vasoconstriction induced by catecholamines, splenic cell mobilization was severalfold higher than expected at increased flow resistance. Propranolol abrogated this effect to a large extent. Furthermore, perfusion of the beta-agonist isoproterenol stimulated lymphoid cell outflow from the spleen despite increased flow resistance. These studies show a dual effect of NE on cell mobilization from the spleen: cell retention by decreasing blood flow and stimulation of cell output by a beta-adrenergically mediated, smooth muscle-independent mechanism. (+info)Vasoconstrictor agents are substances that cause the narrowing of blood vessels by constricting the smooth muscle in their walls. This leads to an increase in blood pressure and a decrease in blood flow. They work by activating the sympathetic nervous system, which triggers the release of neurotransmitters such as norepinephrine and epinephrine that bind to alpha-adrenergic receptors on the smooth muscle cells of the blood vessel walls, causing them to contract.
Vasoconstrictor agents are used medically for a variety of purposes, including:
* Treating hypotension (low blood pressure)
* Controlling bleeding during surgery or childbirth
* Relieving symptoms of nasal congestion in conditions such as the common cold or allergies
Examples of vasoconstrictor agents include phenylephrine, oxymetazoline, and epinephrine. It's important to note that prolonged use or excessive doses of vasoconstrictor agents can lead to rebound congestion and other adverse effects, so they should be used with caution and under the guidance of a healthcare professional.
Norbornanes are a class of compounds in organic chemistry that contain a norbornane skeleton, which is a bicyclic structure consisting of two fused cyclohexane rings. One of the rings is saturated, while the other contains a double bond. The name "norbornane" comes from the fact that it is a "nor" (short for "norcarene") derivative of bornane, which has a similar structure but with a methyl group attached to one of the carbon atoms in the saturated ring.
Norbornanes have a variety of applications in organic synthesis and medicinal chemistry. Some derivatives of norbornane have been explored for their potential as drugs, particularly in the areas of central nervous system agents and anti-inflammatory agents. However, there is no specific medical definition associated with "norbornanes" as they are a class of chemical compounds rather than a medical term or condition.
Vasoconstriction is a medical term that refers to the narrowing of blood vessels due to the contraction of the smooth muscle in their walls. This process decreases the diameter of the lumen (the inner space of the blood vessel) and reduces blood flow through the affected vessels. Vasoconstriction can occur throughout the body, but it is most noticeable in the arterioles and precapillary sphincters, which control the amount of blood that flows into the capillary network.
The autonomic nervous system, specifically the sympathetic division, plays a significant role in regulating vasoconstriction through the release of neurotransmitters like norepinephrine (noradrenaline). Various hormones and chemical mediators, such as angiotensin II, endothelin-1, and serotonin, can also induce vasoconstriction.
Vasoconstriction is a vital physiological response that helps maintain blood pressure and regulate blood flow distribution in the body. However, excessive or prolonged vasoconstriction may contribute to several pathological conditions, including hypertension, stroke, and peripheral vascular diseases.
Phenylephrine is a medication that belongs to the class of drugs known as sympathomimetic amines. It primarily acts as an alpha-1 adrenergic receptor agonist, which means it stimulates these receptors, leading to vasoconstriction (constriction of blood vessels). This effect can be useful in various medical situations, such as:
1. Nasal decongestion: When applied topically in the nose, phenylephrine causes constriction of the blood vessels in the nasal passages, which helps to relieve congestion and swelling. It is often found in over-the-counter (OTC) cold and allergy products.
2. Ocular circulation: In ophthalmology, phenylephrine is used to dilate the pupils before eye examinations. The increased pressure from vasoconstriction helps to open up the pupil, allowing for a better view of the internal structures of the eye.
3. Hypotension management: In some cases, phenylephrine may be given intravenously to treat low blood pressure (hypotension) during medical procedures like spinal anesthesia or septic shock. The vasoconstriction helps to increase blood pressure and improve perfusion of vital organs.
It is essential to use phenylephrine as directed, as improper usage can lead to adverse effects such as increased heart rate, hypertension, arrhythmias, and rebound congestion (when used as a nasal decongestant). Always consult with a healthcare professional for appropriate guidance on using this medication.
Angiotensin II is a potent vasoactive peptide hormone that plays a critical role in the renin-angiotensin-aldosterone system (RAAS), which is a crucial regulator of blood pressure and fluid balance in the body. It is formed from angiotensin I through the action of an enzyme called angiotensin-converting enzyme (ACE).
Angiotensin II has several physiological effects on various organs, including:
1. Vasoconstriction: Angiotensin II causes contraction of vascular smooth muscle, leading to an increase in peripheral vascular resistance and blood pressure.
2. Aldosterone release: Angiotensin II stimulates the adrenal glands to release aldosterone, a hormone that promotes sodium reabsorption and potassium excretion in the kidneys, thereby increasing water retention and blood volume.
3. Sympathetic nervous system activation: Angiotensin II activates the sympathetic nervous system, leading to increased heart rate and contractility, further contributing to an increase in blood pressure.
4. Thirst regulation: Angiotensin II stimulates the hypothalamus to increase thirst, promoting water intake and helping to maintain intravascular volume.
5. Cell growth and fibrosis: Angiotensin II has been implicated in various pathological processes, such as cell growth, proliferation, and fibrosis, which can contribute to the development of cardiovascular and renal diseases.
Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) are two classes of medications commonly used in clinical practice to target the RAAS by blocking the formation or action of angiotensin II, respectively. These drugs have been shown to be effective in managing hypertension, heart failure, and chronic kidney disease.
Norepinephrine, also known as noradrenaline, is a neurotransmitter and a hormone that is primarily produced in the adrenal glands and is released into the bloodstream in response to stress or physical activity. It plays a crucial role in the "fight-or-flight" response by preparing the body for action through increasing heart rate, blood pressure, respiratory rate, and glucose availability.
As a neurotransmitter, norepinephrine is involved in regulating various functions of the nervous system, including attention, perception, motivation, and arousal. It also plays a role in modulating pain perception and responding to stressful or emotional situations.
In medical settings, norepinephrine is used as a vasopressor medication to treat hypotension (low blood pressure) that can occur during septic shock, anesthesia, or other critical illnesses. It works by constricting blood vessels and increasing heart rate, which helps to improve blood pressure and perfusion of vital organs.
Vascular resistance is a measure of the opposition to blood flow within a vessel or a group of vessels, typically expressed in units of mmHg/(mL/min) or sometimes as dynes*sec/cm^5. It is determined by the diameter and length of the vessels, as well as the viscosity of the blood flowing through them. In general, a decrease in vessel diameter, an increase in vessel length, or an increase in blood viscosity will result in an increase in vascular resistance, while an increase in vessel diameter, a decrease in vessel length, or a decrease in blood viscosity will result in a decrease in vascular resistance. Vascular resistance is an important concept in the study of circulation and cardiovascular physiology because it plays a key role in determining blood pressure and blood flow within the body.
A smooth muscle within the vascular system refers to the involuntary, innervated muscle that is found in the walls of blood vessels. These muscles are responsible for controlling the diameter of the blood vessels, which in turn regulates blood flow and blood pressure. They are called "smooth" muscles because their individual muscle cells do not have the striations, or cross-striped patterns, that are observed in skeletal and cardiac muscle cells. Smooth muscle in the vascular system is controlled by the autonomic nervous system and by hormones, and can contract or relax slowly over a period of time.
Blood pressure is the force exerted by circulating blood on the walls of the blood vessels. It is measured in millimeters of mercury (mmHg) and is given as two figures:
1. Systolic pressure: This is the pressure when the heart pushes blood out into the arteries.
2. Diastolic pressure: This is the pressure when the heart rests between beats, allowing it to fill with blood.
Normal blood pressure for adults is typically around 120/80 mmHg, although this can vary slightly depending on age, sex, and other factors. High blood pressure (hypertension) is generally considered to be a reading of 130/80 mmHg or higher, while low blood pressure (hypotension) is usually defined as a reading below 90/60 mmHg. It's important to note that blood pressure can fluctuate throughout the day and may be affected by factors such as stress, physical activity, and medication use.
Endothelin is a type of peptide (small protein) that is produced by the endothelial cells, which line the interior surface of blood vessels. Endothelins are known to be potent vasoconstrictors, meaning they cause the narrowing of blood vessels, and thus increase blood pressure. There are three major types of endothelin molecules, known as Endothelin-1, Endothelin-2, and Endothelin-3. These endothelins bind to specific receptors (ETA, ETB) on the surface of smooth muscle cells in the blood vessel walls, leading to contraction and subsequent vasoconstriction. Additionally, endothelins have been implicated in various physiological and pathophysiological processes such as regulation of cell growth, inflammation, and fibrosis.
Endothelin-1 is a small peptide (21 amino acids) and a potent vasoconstrictor, which means it narrows blood vessels. It is primarily produced by the endothelial cells that line the interior surface of blood vessels. Endothelin-1 plays a crucial role in regulating vascular tone, cell growth, and inflammation. Its dysregulation has been implicated in various cardiovascular diseases, such as hypertension and heart failure. It exerts its effects by binding to specific G protein-coupled receptors (ETA and ETB) on the surface of target cells.
The mesenteric arteries are the arteries that supply oxygenated blood to the intestines. There are three main mesenteric arteries: the superior mesenteric artery, which supplies blood to the small intestine (duodenum to two-thirds of the transverse colon) and large intestine (cecum, ascending colon, and the first part of the transverse colon); the inferior mesenteric artery, which supplies blood to the distal third of the transverse colon, descending colon, sigmoid colon, and rectum; and the middle colic artery, which is a branch of the superior mesenteric artery that supplies blood to the transverse colon. These arteries are important in maintaining adequate blood flow to the intestines to support digestion and absorption of nutrients.
Regional blood flow (RBF) refers to the rate at which blood flows through a specific region or organ in the body, typically expressed in milliliters per minute per 100 grams of tissue (ml/min/100g). It is an essential physiological parameter that reflects the delivery of oxygen and nutrients to tissues while removing waste products. RBF can be affected by various factors such as metabolic demands, neural regulation, hormonal influences, and changes in blood pressure or vascular resistance. Measuring RBF is crucial for understanding organ function, diagnosing diseases, and evaluating the effectiveness of treatments.
The sympathetic nervous system (SNS) is a part of the autonomic nervous system that operates largely below the level of consciousness, and it functions to produce appropriate physiological responses to perceived danger. It's often associated with the "fight or flight" response. The SNS uses nerve impulses to stimulate target organs, causing them to speed up (e.g., increased heart rate), prepare for action, or otherwise respond to stressful situations.
The sympathetic nervous system is activated due to stressful emotional or physical situations and it prepares the body for immediate actions. It dilates the pupils, increases heart rate and blood pressure, accelerates breathing, and slows down digestion. The primary neurotransmitter involved in this system is norepinephrine (also known as noradrenaline).
The vasomotor system is a part of the autonomic nervous system that controls the diameter of blood vessels, particularly the smooth muscle in the walls of arterioles and precapillary sphincters. It regulates blood flow to different parts of the body by constricting or dilating these vessels. The vasomotor center located in the medulla oblongata of the brainstem controls the system, receiving input from various sensory receptors and modulating the sympathetic and parasympathetic nervous systems' activity. Vasoconstriction decreases blood flow, while vasodilation increases it.
Endothelin receptors are a type of G protein-coupled receptor that bind to endothelin, a potent vasoconstrictor peptide. There are two main types of endothelin receptors: ETA and ETB. ETA receptors are found in vascular smooth muscle cells and activate phospholipase C, leading to an increase in intracellular calcium and subsequent contraction of the smooth muscle. ETB receptors are found in both endothelial cells and vascular smooth muscle cells. In endothelial cells, ETB receptor activation leads to the release of nitric oxide and prostacyclin, which cause vasodilation. In vascular smooth muscle cells, ETB receptor activation causes vasoconstriction through a mechanism that is not fully understood.
Endothelin receptors play important roles in regulating blood flow, vascular remodeling, and the development of cardiovascular diseases such as hypertension and heart failure. They are also involved in the regulation of cell growth, differentiation, and apoptosis in various tissues.
Vasodilation is the widening or increase in diameter of blood vessels, particularly the involuntary relaxation of the smooth muscle in the tunica media (middle layer) of the arteriole walls. This results in an increase in blood flow and a decrease in vascular resistance. Vasodilation can occur due to various physiological and pathophysiological stimuli, such as local metabolic demands, neural signals, or pharmacological agents. It plays a crucial role in regulating blood pressure, tissue perfusion, and thermoregulation.
Vasodilator agents are pharmacological substances that cause the relaxation or widening of blood vessels by relaxing the smooth muscle in the vessel walls. This results in an increase in the diameter of the blood vessels, which decreases vascular resistance and ultimately reduces blood pressure. Vasodilators can be further classified based on their site of action:
1. Systemic vasodilators: These agents cause a generalized relaxation of the smooth muscle in the walls of both arteries and veins, resulting in a decrease in peripheral vascular resistance and preload (the volume of blood returning to the heart). Examples include nitroglycerin, hydralazine, and calcium channel blockers.
2. Arterial vasodilators: These agents primarily affect the smooth muscle in arterial vessel walls, leading to a reduction in afterload (the pressure against which the heart pumps blood). Examples include angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), and direct vasodilators like sodium nitroprusside.
3. Venous vasodilators: These agents primarily affect the smooth muscle in venous vessel walls, increasing venous capacitance and reducing preload. Examples include nitroglycerin and other organic nitrates.
Vasodilator agents are used to treat various cardiovascular conditions such as hypertension, heart failure, angina, and pulmonary arterial hypertension. It is essential to monitor their use carefully, as excessive vasodilation can lead to orthostatic hypotension, reflex tachycardia, or fluid retention.
Methoxamine is a synthetic, selective α1-adrenergic receptor agonist used in scientific research and for therapeutic purposes. It has the ability to stimulate the α1 adrenergic receptors, leading to vasoconstriction (constriction of blood vessels), increased blood pressure, and reduced blood flow to the skin and extremities.
In a medical context, methoxamine is primarily used as an experimental drug or in research settings due to its specific pharmacological properties. It may be employed to investigate the role of α1-adrenergic receptors in various physiological processes or to temporarily counteract the hypotensive (low blood pressure) effects of certain medications, such as vasodilators or anesthetics.
It is important to note that methoxamine is not commonly used in routine clinical practice due to its strong vasoconstrictive properties and potential adverse effects on organ function if misused or improperly dosed.
The forearm is the region of the upper limb between the elbow and the wrist. It consists of two bones, the radius and ulna, which are located side by side and run parallel to each other. The forearm is responsible for movements such as flexion, extension, supination, and pronation of the hand and wrist.
Endothelin A (ETA) receptor is a type of G protein-coupled receptor that is activated by the peptide hormone endothelin-1, endothelin-2, and endothelin-3. It is widely expressed in various tissues and organs, including vascular smooth muscle cells, cardiac myocytes, fibroblasts, and kidney cells. Activation of ETA receptor leads to vasoconstriction, increased cell proliferation, and fibrosis, which contribute to the development of hypertension, heart failure, and chronic kidney disease. Therefore, ETA receptor antagonists have been developed as potential therapeutic agents for these conditions.
Renal circulation refers to the blood flow specifically dedicated to the kidneys. The main function of the kidneys is to filter waste and excess fluids from the blood, which then get excreted as urine. To perform this function efficiently, the kidneys receive a substantial amount of the body's total blood supply - about 20-25% in a resting state.
The renal circulation process begins when deoxygenated blood from the rest of the body returns to the right side of the heart and is pumped into the lungs for oxygenation. Oxygen-rich blood then leaves the left side of the heart through the aorta, the largest artery in the body.
A portion of this oxygen-rich blood moves into the renal arteries, which branch directly from the aorta and supply each kidney with blood. Within the kidneys, these arteries divide further into smaller vessels called afferent arterioles, which feed into a network of tiny capillaries called the glomerulus within each nephron (the functional unit of the kidney).
The filtration process occurs in the glomeruli, where waste materials and excess fluids are separated from the blood. The resulting filtrate then moves through another set of capillaries, the peritubular capillaries, which surround the renal tubules (the part of the nephron that reabsorbs necessary substances back into the bloodstream).
The now-deoxygenated blood from the kidneys' capillary network coalesces into venules and then merges into the renal veins, which ultimately drain into the inferior vena cava and return the blood to the right side of the heart. This highly specialized circulation system allows the kidneys to efficiently filter waste while maintaining appropriate blood volume and composition.
Tyramine is not a medical condition but a naturally occurring compound called a biogenic amine, which is formed from the amino acid tyrosine during the fermentation or decay of certain foods. Medically, tyramine is significant because it can interact with certain medications, particularly monoamine oxidase inhibitors (MAOIs), used to treat depression and other conditions.
The interaction between tyramine and MAOIs can lead to a hypertensive crisis, a rapid and severe increase in blood pressure, which can be life-threatening if not treated promptly. Therefore, individuals taking MAOIs are often advised to follow a low-tyramine diet, avoiding foods high in tyramine, such as aged cheeses, cured meats, fermented foods, and some types of beer and wine.
Nitric oxide (NO) is a molecule made up of one nitrogen atom and one oxygen atom. In the body, it is a crucial signaling molecule involved in various physiological processes such as vasodilation, immune response, neurotransmission, and inhibition of platelet aggregation. It is produced naturally by the enzyme nitric oxide synthase (NOS) from the amino acid L-arginine. Inhaled nitric oxide is used medically to treat pulmonary hypertension in newborns and adults, as it helps to relax and widen blood vessels, improving oxygenation and blood flow.
Thromboxane A2 (TXA2) is a potent prostanoid, a type of lipid compound derived from arachidonic acid. It is primarily produced and released by platelets upon activation during the process of hemostasis (the body's response to stop bleeding). TXA2 acts as a powerful vasoconstrictor, causing blood vessels to narrow, which helps limit blood loss at the site of injury. Additionally, it promotes platelet aggregation, contributing to the formation of a stable clot and preventing further bleeding. However, uncontrolled or excessive production of TXA2 can lead to thrombotic events such as heart attacks and strokes. Its effects are balanced by prostacyclin (PGI2), which is produced by endothelial cells and has opposing actions, acting as a vasodilator and inhibiting platelet aggregation. The balance between TXA2 and PGI2 helps maintain vascular homeostasis.
The Endothelin B (ETB) receptor is a type of G protein-coupled receptor that binds to endothelin, a potent vasoconstrictor peptide. ETB receptors are expressed in various tissues, including vascular endothelial cells and smooth muscle cells. When endothelin binds to the ETB receptor, it can cause both vasodilation and vasoconstriction, depending on the location of the receptor. In endothelial cells, activation of ETB receptors leads to the production of nitric oxide, a potent vasodilator. However, in vascular smooth muscle cells, activation of ETB receptors can cause vasoconstriction by increasing intracellular calcium levels.
ETB receptors have also been implicated in various physiological and pathophysiological processes, including cardiovascular function, kidney function, and neurotransmission. In the cardiovascular system, ETB receptors play a role in regulating blood pressure and vascular remodeling. In the kidneys, they are involved in the regulation of sodium and water balance. Additionally, ETB receptors have been implicated in the development of pulmonary hypertension, heart failure, and chronic kidney disease.
Overall, Endothelin B receptors play a critical role in regulating various physiological processes, and their dysregulation has been associated with several pathological conditions.
Arterioles are small branches of arteries that play a crucial role in regulating blood flow and blood pressure within the body's circulatory system. They are the smallest type of blood vessels that have muscular walls, which allow them to contract or dilate in response to various physiological signals.
Arterioles receive blood from upstream arteries and deliver it to downstream capillaries, where the exchange of oxygen, nutrients, and waste products occurs between the blood and surrounding tissues. The contraction of arteriolar muscles can reduce the diameter of these vessels, causing increased resistance to blood flow and leading to a rise in blood pressure upstream. Conversely, dilation of arterioles reduces resistance and allows for greater blood flow at a lower pressure.
The regulation of arteriolar tone is primarily controlled by the autonomic nervous system, local metabolic factors, and various hormones. This fine-tuning of arteriolar diameter enables the body to maintain adequate blood perfusion to vital organs while also controlling overall blood pressure and distribution.
Arteries are blood vessels that carry oxygenated blood away from the heart to the rest of the body. They have thick, muscular walls that can withstand the high pressure of blood being pumped out of the heart. Arteries branch off into smaller vessels called arterioles, which further divide into a vast network of tiny capillaries where the exchange of oxygen, nutrients, and waste occurs between the blood and the body's cells. After passing through the capillary network, deoxygenated blood collects in venules, then merges into veins, which return the blood back to the heart.
The endothelium is a thin layer of simple squamous epithelial cells that lines the interior surface of blood vessels, lymphatic vessels, and heart chambers. The vascular endothelium, specifically, refers to the endothelial cells that line the blood vessels. These cells play a crucial role in maintaining vascular homeostasis by regulating vasomotor tone, coagulation, platelet activation, inflammation, and permeability of the vessel wall. They also contribute to the growth and repair of the vascular system and are involved in various pathological processes such as atherosclerosis, hypertension, and diabetes.
Hemodynamics is the study of how blood flows through the cardiovascular system, including the heart and the vascular network. It examines various factors that affect blood flow, such as blood volume, viscosity, vessel length and diameter, and pressure differences between different parts of the circulatory system. Hemodynamics also considers the impact of various physiological and pathological conditions on these variables, and how they in turn influence the function of vital organs and systems in the body. It is a critical area of study in fields such as cardiology, anesthesiology, and critical care medicine.
A dose-response relationship in the context of drugs refers to the changes in the effects or symptoms that occur as the dose of a drug is increased or decreased. Generally, as the dose of a drug is increased, the severity or intensity of its effects also increases. Conversely, as the dose is decreased, the effects of the drug become less severe or may disappear altogether.
The dose-response relationship is an important concept in pharmacology and toxicology because it helps to establish the safe and effective dosage range for a drug. By understanding how changes in the dose of a drug affect its therapeutic and adverse effects, healthcare providers can optimize treatment plans for their patients while minimizing the risk of harm.
The dose-response relationship is typically depicted as a curve that shows the relationship between the dose of a drug and its effect. The shape of the curve may vary depending on the drug and the specific effect being measured. Some drugs may have a steep dose-response curve, meaning that small changes in the dose can result in large differences in the effect. Other drugs may have a more gradual dose-response curve, where larger changes in the dose are needed to produce significant effects.
In addition to helping establish safe and effective dosages, the dose-response relationship is also used to evaluate the potential therapeutic benefits and risks of new drugs during clinical trials. By systematically testing different doses of a drug in controlled studies, researchers can identify the optimal dosage range for the drug and assess its safety and efficacy.
Prostaglandin endoperoxides are naturally occurring lipid compounds that play important roles as mediators in the body's inflammatory and physiological responses. They are intermediate products in the conversion of arachidonic acid to prostaglandins and thromboxanes, which are synthesized by the action of enzymes called cyclooxygenases (COX-1 and COX-2).
Synthetic prostaglandin endoperoxides, on the other hand, are chemically synthesized versions of these compounds. They are used in medical research and therapeutic applications to mimic or inhibit the effects of naturally occurring prostaglandin endoperoxides. These synthetic compounds can be used to study the mechanisms of prostaglandin action, develop new drugs, or as stand-in agents for the natural compounds in experimental settings.
It's important to note that while synthetic prostaglandin endoperoxides can serve as useful tools in research and medicine, they also carry potential risks and side effects, much like their naturally occurring counterparts. Therefore, their use should be carefully monitored and regulated to ensure safety and efficacy.
Urotensins are a group of peptides that play a role in the cardiovascular system. The most well-known member of this family is urotensin II, which is a potent vasoconstrictor and has been implicated in various cardiovascular disorders such as hypertension, heart failure, and atherosclerosis. Urotensins are found in many species, including humans, and are derived from a precursor protein called urotensin II-related peptide (URP). In addition to urotensin II, other related peptides such as urotensin I, urotensin III, and urotensin IV have also been identified, but their functions are less well understood.
NG-Nitroarginine Methyl Ester (L-NAME) is not a medication, but rather a research chemical used in scientific studies. It is an inhibitor of nitric oxide synthase, an enzyme that synthesizes nitric oxide, a molecule involved in the relaxation of blood vessels.
Therefore, L-NAME is often used in experiments to investigate the role of nitric oxide in various physiological and pathophysiological processes. It is important to note that the use of L-NAME in humans is not approved for therapeutic purposes due to its potential side effects, which can include hypertension, decreased renal function, and decreased cerebral blood flow.
Potassium chloride is an essential electrolyte that is often used in medical settings as a medication. It's a white, crystalline salt that is highly soluble in water and has a salty taste. In the body, potassium chloride plays a crucial role in maintaining fluid and electrolyte balance, nerve function, and muscle contraction.
Medically, potassium chloride is commonly used to treat or prevent low potassium levels (hypokalemia) in the blood. Hypokalemia can occur due to various reasons such as certain medications, kidney diseases, vomiting, diarrhea, or excessive sweating. Potassium chloride is available in various forms, including tablets, capsules, and liquids, and it's usually taken by mouth.
It's important to note that potassium chloride should be used with caution and under the supervision of a healthcare provider, as high levels of potassium (hyperkalemia) can be harmful and even life-threatening. Hyperkalemia can cause symptoms such as muscle weakness, irregular heartbeat, and cardiac arrest.
Indomethacin is a non-steroidal anti-inflammatory drug (NSAID) that is commonly used to reduce pain, inflammation, and fever. It works by inhibiting the activity of certain enzymes in the body, including cyclooxygenase (COX), which plays a role in producing prostaglandins, chemicals involved in the inflammatory response.
Indomethacin is available in various forms, such as capsules, suppositories, and injectable solutions, and is used to treat a wide range of conditions, including rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, gout, and bursitis. It may also be used to relieve pain and reduce fever in other conditions, such as dental procedures or after surgery.
Like all NSAIDs, indomethacin can have side effects, including stomach ulcers, bleeding, and kidney damage, especially when taken at high doses or for long periods of time. It may also increase the risk of heart attack and stroke. Therefore, it is important to use indomethacin only as directed by a healthcare provider and to report any unusual symptoms or side effects promptly.
Adrenergic alpha-agonists are a type of medication that binds to and activates adrenergic alpha receptors, which are found in the nervous system and other tissues throughout the body. These receptors are activated naturally by chemicals called catecholamines, such as norepinephrine and epinephrine (also known as adrenaline), that are released in response to stress or excitement.
When adrenergic alpha-agonists bind to these receptors, they mimic the effects of catecholamines and cause various physiological responses, such as vasoconstriction (constriction of blood vessels), increased heart rate and force of heart contractions, and relaxation of smooth muscle in the airways.
Adrenergic alpha-agonists are used to treat a variety of medical conditions, including hypertension (high blood pressure), glaucoma, nasal congestion, and attention deficit hyperactivity disorder (ADHD). Examples of adrenergic alpha-agonists include phenylephrine, clonidine, and guanfacine.
It's important to note that adrenergic alpha-agonists can have both beneficial and harmful effects, depending on the specific medication, dosage, and individual patient factors. Therefore, they should only be used under the guidance of a healthcare professional.
Sprague-Dawley rats are a strain of albino laboratory rats that are widely used in scientific research. They were first developed by researchers H.H. Sprague and R.C. Dawley in the early 20th century, and have since become one of the most commonly used rat strains in biomedical research due to their relatively large size, ease of handling, and consistent genetic background.
Sprague-Dawley rats are outbred, which means that they are genetically diverse and do not suffer from the same limitations as inbred strains, which can have reduced fertility and increased susceptibility to certain diseases. They are also characterized by their docile nature and low levels of aggression, making them easier to handle and study than some other rat strains.
These rats are used in a wide variety of research areas, including toxicology, pharmacology, nutrition, cancer, and behavioral studies. Because they are genetically diverse, Sprague-Dawley rats can be used to model a range of human diseases and conditions, making them an important tool in the development of new drugs and therapies.
Perfusion, in medical terms, refers to the process of circulating blood through the body's organs and tissues to deliver oxygen and nutrients and remove waste products. It is a measure of the delivery of adequate blood flow to specific areas or tissues in the body. Perfusion can be assessed using various methods, including imaging techniques like computed tomography (CT) scans, magnetic resonance imaging (MRI), and perfusion scintigraphy.
Perfusion is critical for maintaining proper organ function and overall health. When perfusion is impaired or inadequate, it can lead to tissue hypoxia, acidosis, and cell death, which can result in organ dysfunction or failure. Conditions that can affect perfusion include cardiovascular disease, shock, trauma, and certain surgical procedures.
Thromboxane receptors are a type of G protein-coupled receptor that binds thromboxane A2 (TXA2), a powerful inflammatory mediator and vasoconstrictor synthesized in the body from arachidonic acid. These receptors play a crucial role in various physiological processes, including platelet aggregation, smooth muscle contraction, and modulation of immune responses.
There are two main types of thromboxane receptors: TPα and TPβ. The TPα receptor is primarily found on platelets and vascular smooth muscle cells, while the TPβ receptor is expressed in various tissues such as the kidney, lung, and brain. Activation of these receptors by thromboxane A2 leads to a variety of cellular responses, including platelet activation and aggregation, vasoconstriction, and inflammation.
Abnormalities in thromboxane receptor function have been implicated in several pathological conditions, such as cardiovascular diseases, asthma, and cancer. Therefore, thromboxane receptors are an important target for the development of therapeutic agents to treat these disorders.
nitroprusside (ni-troe-rus-ide)
A rapid-acting vasodilator used in the management of severe hypertension, acute heart failure, and to reduce afterload in patients undergoing cardiac surgery. It is a potent arterial and venous dilator that decreases preload and afterload, thereby reducing myocardial oxygen demand. Nitroprusside is metabolized to cyanide, which must be monitored closely during therapy to prevent toxicity.
Pharmacologic class: Peripheral vasodilators
Therapeutic class: Antihypertensives, Vasodilators
Medical Categories: Cardiovascular Drugs, Hypertension Agents
I believe there might be a misunderstanding in your question. "Dogs" is not a medical term or condition. It is the common name for a domesticated carnivore of the family Canidae, specifically the genus Canis, which includes wolves, foxes, and other extant and extinct species of mammals. Dogs are often kept as pets and companions, and they have been bred in a wide variety of forms and sizes for different purposes, such as hunting, herding, guarding, assisting police and military forces, and providing companionship and emotional support.
If you meant to ask about a specific medical condition or term related to dogs, please provide more context so I can give you an accurate answer.
Splanchnic circulation refers to the blood flow to the visceral organs, including the gastrointestinal tract, pancreas, spleen, and liver. These organs receive a significant portion of the cardiac output, with approximately 25-30% of the total restingly going to the splanchnic circulation. The splanchnic circulation is regulated by a complex interplay of neural and hormonal mechanisms that help maintain adequate blood flow to these vital organs while also allowing for the distribution of blood to other parts of the body as needed.
The splanchnic circulation is unique in its ability to vasodilate and increase blood flow significantly in response to meals or other stimuli, such as stress or hormonal changes. This increased blood flow helps support the digestive process and absorption of nutrients. At the same time, the body must carefully regulate this blood flow to prevent a significant drop in blood pressure or overloading the heart with too much work.
Overall, the splanchnic circulation plays a critical role in maintaining the health and function of the body's vital organs, and dysregulation of this system can contribute to various diseases, including digestive disorders, liver disease, and cardiovascular disease.
Serotonin, also known as 5-hydroxytryptamine (5-HT), is a monoamine neurotransmitter that is found primarily in the gastrointestinal (GI) tract, blood platelets, and the central nervous system (CNS) of humans and other animals. It is produced by the conversion of the amino acid tryptophan to 5-hydroxytryptophan (5-HTP), and then to serotonin.
In the CNS, serotonin plays a role in regulating mood, appetite, sleep, memory, learning, and behavior, among other functions. It also acts as a vasoconstrictor, helping to regulate blood flow and blood pressure. In the GI tract, it is involved in peristalsis, the contraction and relaxation of muscles that moves food through the digestive system.
Serotonin is synthesized and stored in serotonergic neurons, which are nerve cells that use serotonin as their primary neurotransmitter. These neurons are found throughout the brain and spinal cord, and they communicate with other neurons by releasing serotonin into the synapse, the small gap between two neurons.
Abnormal levels of serotonin have been linked to a variety of disorders, including depression, anxiety, schizophrenia, and migraines. Medications that affect serotonin levels, such as selective serotonin reuptake inhibitors (SSRIs), are commonly used to treat these conditions.
Muscle tonus, also known as muscle tone, refers to the continuous and passive partial contraction of the muscles, which helps to maintain posture and stability. It is the steady state of slight tension that is present in resting muscles, allowing them to quickly respond to stimuli and move. This natural state of mild contraction is maintained by the involuntary activity of the nervous system and can be affected by factors such as injury, disease, or exercise.
It's important to note that muscle tone should not be confused with muscle "tone" in the context of physical appearance or body sculpting, which refers to the amount of muscle definition and leanness seen in an individual's physique.
Nordefrin is not typically used as a medical diagnosis or treatment, but it is a medication that contains the active ingredient Noradrenaline (also known as Norepinephrine) which is a naturally occurring hormone and neurotransmitter in the human body.
Noradrenaline is a potent vasoconstrictor, increasing blood pressure and improving blood flow to vital organs such as the heart and brain. It also acts as a bronchodilator, opening up the airways in the lungs. Nordefrin is used as a medication to treat hypotension (low blood pressure) and shock, particularly in cases where other treatments have been ineffective.
It's important to note that Nordefrin should only be administered under the supervision of a healthcare professional, as it can have serious side effects if not used correctly.
Hydroxyeicosatetraenoic acids (HETEs) are a type of metabolite produced by the oxidation of arachidonic acid, a polyunsaturated fatty acid that is found in the membranes of cells in the human body. This oxidation process is catalyzed by enzymes called lipoxygenases (LOXs) and cytochrome P450 monooxygenases (CYP450).
HETEs are biologically active compounds that play a role in various physiological and pathophysiological processes, including inflammation, immune response, and cancer. They can act as signaling molecules, modulating the activity of various cell types, such as leukocytes, endothelial cells, and smooth muscle cells.
There are several different types of HETEs, depending on the position of the hydroxyl group (-OH) attached to the arachidonic acid molecule. For example, 5-HETE, 12-HETE, and 15-HETE are produced by 5-LOX, 12-LOX, and 15-LOX, respectively, while CYP450 can produce 20-HETE.
It's worth noting that HETEs have been implicated in various diseases, such as atherosclerosis, hypertension, and cancer, making them potential targets for therapeutic intervention. However, further research is needed to fully understand their roles and develop effective treatments.
Nitric Oxide Synthase (NOS) is a group of enzymes that catalyze the production of nitric oxide (NO) from L-arginine. There are three distinct isoforms of NOS, each with different expression patterns and functions:
1. Neuronal Nitric Oxide Synthase (nNOS or NOS1): This isoform is primarily expressed in the nervous system and plays a role in neurotransmission, synaptic plasticity, and learning and memory processes.
2. Inducible Nitric Oxide Synthase (iNOS or NOS2): This isoform is induced by various stimuli such as cytokines, lipopolysaccharides, and hypoxia in a variety of cells including immune cells, endothelial cells, and smooth muscle cells. iNOS produces large amounts of NO, which functions as a potent effector molecule in the immune response, particularly in the defense against microbial pathogens.
3. Endothelial Nitric Oxide Synthase (eNOS or NOS3): This isoform is constitutively expressed in endothelial cells and produces low levels of NO that play a crucial role in maintaining vascular homeostasis by regulating vasodilation, inhibiting platelet aggregation, and preventing smooth muscle cell proliferation.
Overall, NOS plays an essential role in various physiological processes, including neurotransmission, immune response, cardiovascular function, and respiratory regulation. Dysregulation of NOS activity has been implicated in several pathological conditions such as hypertension, atherosclerosis, neurodegenerative diseases, and inflammatory disorders.
Prostaglandins are naturally occurring, lipid-derived hormones that play various important roles in the human body. They are produced in nearly every tissue in response to injury or infection, and they have diverse effects depending on the site of release and the type of prostaglandin. Some of their functions include:
1. Regulation of inflammation: Prostaglandins contribute to the inflammatory response by increasing vasodilation, promoting fluid accumulation, and sensitizing pain receptors, which can lead to symptoms such as redness, heat, swelling, and pain.
2. Modulation of gastrointestinal functions: Prostaglandins protect the stomach lining from acid secretion and promote mucus production, maintaining the integrity of the gastric mucosa. They also regulate intestinal motility and secretion.
3. Control of renal function: Prostaglandins help regulate blood flow to the kidneys, maintain sodium balance, and control renin release, which affects blood pressure and fluid balance.
4. Regulation of smooth muscle contraction: Prostaglandins can cause both relaxation and contraction of smooth muscles in various tissues, such as the uterus, bronchioles, and vascular system.
5. Modulation of platelet aggregation: Some prostaglandins inhibit platelet aggregation, preventing blood clots from forming too quickly or becoming too large.
6. Reproductive system regulation: Prostaglandins are involved in the menstrual cycle, ovulation, and labor induction by promoting uterine contractions.
7. Neurotransmission: Prostaglandins can modulate neurotransmitter release and neuronal excitability, affecting pain perception, mood, and cognition.
Prostaglandins exert their effects through specific G protein-coupled receptors (GPCRs) found on the surface of target cells. There are several distinct types of prostaglandins (PGs), including PGD2, PGE2, PGF2α, PGI2 (prostacyclin), and thromboxane A2 (TXA2). Each type has unique functions and acts through specific receptors. Prostaglandins are synthesized from arachidonic acid, a polyunsaturated fatty acid derived from membrane phospholipids, by the action of cyclooxygenase (COX) enzymes. Nonsteroidal anti-inflammatory drugs (NSAIDs), such as aspirin and ibuprofen, inhibit COX activity, reducing prostaglandin synthesis and providing analgesic, anti-inflammatory, and antipyretic effects.
Acetylcholine is a neurotransmitter, a type of chemical messenger that transmits signals across a chemical synapse from one neuron (nerve cell) to another "target" neuron, muscle cell, or gland cell. It is involved in both peripheral and central nervous system functions.
In the peripheral nervous system, acetylcholine acts as a neurotransmitter at the neuromuscular junction, where it transmits signals from motor neurons to activate muscles. Acetylcholine also acts as a neurotransmitter in the autonomic nervous system, where it is involved in both the sympathetic and parasympathetic systems.
In the central nervous system, acetylcholine plays a role in learning, memory, attention, and arousal. Disruptions in cholinergic neurotransmission have been implicated in several neurological disorders, including Alzheimer's disease, Parkinson's disease, and myasthenia gravis.
Acetylcholine is synthesized from choline and acetyl-CoA by the enzyme choline acetyltransferase and is stored in vesicles at the presynaptic terminal of the neuron. When a nerve impulse arrives, the vesicles fuse with the presynaptic membrane, releasing acetylcholine into the synapse. The acetylcholine then binds to receptors on the postsynaptic membrane, triggering a response in the target cell. Acetylcholine is subsequently degraded by the enzyme acetylcholinesterase, which terminates its action and allows for signal transduction to be repeated.
"Viper venoms" refer to the toxic secretions produced by members of the Viperidae family of snakes, which include pit vipers (such as rattlesnakes, copperheads, and cottonmouths) and true vipers (like adders, vipers, and gaboon vipers). These venoms are complex mixtures of proteins, enzymes, and other bioactive molecules that can cause a wide range of symptoms in prey or predators, including local tissue damage, pain, swelling, bleeding, and potentially life-threatening systemic effects such as coagulopathy, cardiovascular shock, and respiratory failure.
The composition of viper venoms varies widely between different species and even among individuals within the same species. However, many viper venoms contain a variety of enzymes (such as phospholipases A2, metalloproteinases, and serine proteases) that can cause tissue damage and disrupt vital physiological processes in the victim. Additionally, some viper venoms contain neurotoxins that can affect the nervous system and cause paralysis or other neurological symptoms.
Understanding the composition and mechanisms of action of viper venoms is important for developing effective treatments for venomous snakebites, as well as for gaining insights into the evolution and ecology of these fascinating and diverse creatures.
Cyclic peptides are a type of peptides in which the N-terminus and C-terminus of the peptide chain are linked to form a circular structure. This is in contrast to linear peptides, which have a straight peptide backbone with a free N-terminus and C-terminus. The cyclization of peptides can occur through various mechanisms, including the formation of an amide bond between the N-terminal amino group and the C-terminal carboxylic acid group (head-to-tail cyclization), or through the formation of a bond between side chain functional groups.
Cyclic peptides have unique structural and chemical properties that make them valuable in medical and therapeutic applications. For example, they are more resistant to degradation by enzymes compared to linear peptides, which can increase their stability and half-life in the body. Additionally, the cyclic structure allows for greater conformational rigidity, which can enhance their binding affinity and specificity to target molecules.
Cyclic peptides have been explored as potential therapeutics for a variety of diseases, including cancer, infectious diseases, and neurological disorders. They have also been used as tools in basic research to study protein-protein interactions and cell signaling pathways.
The renal artery is a pair of blood vessels that originate from the abdominal aorta and supply oxygenated blood to each kidney. These arteries branch into several smaller vessels that provide blood to the various parts of the kidneys, including the renal cortex and medulla. The renal arteries also carry nutrients and other essential components needed for the normal functioning of the kidneys. Any damage or blockage to the renal artery can lead to serious consequences, such as reduced kidney function or even kidney failure.
Adrenergic alpha-antagonists, also known as alpha-blockers, are a class of medications that block the effects of adrenaline and noradrenaline at alpha-adrenergic receptors. These receptors are found in various tissues throughout the body, including the smooth muscle of blood vessels, the heart, the genitourinary system, and the eyes.
When alpha-blockers bind to these receptors, they prevent the activation of the sympathetic nervous system, which is responsible for the "fight or flight" response. This results in a relaxation of the smooth muscle, leading to vasodilation (widening of blood vessels), decreased blood pressure, and increased blood flow.
Alpha-blockers are used to treat various medical conditions, such as hypertension (high blood pressure), benign prostatic hyperplasia (enlarged prostate), pheochromocytoma (a rare tumor of the adrenal gland), and certain types of glaucoma.
Examples of alpha-blockers include doxazosin, prazosin, terazosin, and tamsulosin. Side effects of alpha-blockers may include dizziness, lightheadedness, headache, weakness, and orthostatic hypotension (a sudden drop in blood pressure upon standing).
Sumatriptan is a selective serotonin receptor agonist, specifically targeting the 5-HT1D and 5-HT1B receptors. It is primarily used to treat migraines and cluster headaches. Sumatriptan works by narrowing blood vessels around the brain and reducing inflammation that leads to migraine symptoms.
The medication comes in various forms, including tablets, injectables, and nasal sprays. Common side effects of sumatriptan include feelings of warmth or hotness, tingling, tightness, pressure, heaviness, pain, or burning in the neck, throat, jaw, chest, or arms.
It is important to note that sumatriptan should not be used if a patient has a history of heart disease, stroke, or uncontrolled high blood pressure. Additionally, it should not be taken within 24 hours of using another migraine medication containing ergotamine or similar drugs such as dihydroergotamine, methysergide, or caffeine-containing analgesics.
Pulmonary circulation refers to the process of blood flow through the lungs, where blood picks up oxygen and releases carbon dioxide. This is a vital part of the overall circulatory system, which delivers nutrients and oxygen to the body's cells while removing waste products like carbon dioxide.
In pulmonary circulation, deoxygenated blood from the systemic circulation returns to the right atrium of the heart via the superior and inferior vena cava. The blood then moves into the right ventricle through the tricuspid valve and gets pumped into the pulmonary artery when the right ventricle contracts.
The pulmonary artery divides into smaller vessels called arterioles, which further branch into a vast network of tiny capillaries in the lungs. Here, oxygen from the alveoli diffuses into the blood, binding to hemoglobin in red blood cells, while carbon dioxide leaves the blood and is exhaled through the nose or mouth.
The now oxygenated blood collects in venules, which merge to form pulmonary veins. These veins transport the oxygen-rich blood back to the left atrium of the heart, where it enters the systemic circulation once again. This continuous cycle enables the body's cells to receive the necessary oxygen and nutrients for proper functioning while disposing of waste products.
"Wistar rats" are a strain of albino rats that are widely used in laboratory research. They were developed at the Wistar Institute in Philadelphia, USA, and were first introduced in 1906. Wistar rats are outbred, which means that they are genetically diverse and do not have a fixed set of genetic characteristics like inbred strains.
Wistar rats are commonly used as animal models in biomedical research because of their size, ease of handling, and relatively low cost. They are used in a wide range of research areas, including toxicology, pharmacology, nutrition, cancer, cardiovascular disease, and behavioral studies. Wistar rats are also used in safety testing of drugs, medical devices, and other products.
Wistar rats are typically larger than many other rat strains, with males weighing between 500-700 grams and females weighing between 250-350 grams. They have a lifespan of approximately 2-3 years. Wistar rats are also known for their docile and friendly nature, making them easy to handle and work with in the laboratory setting.
Arginine vasopressin (AVP), also known as antidiuretic hormone (ADH), is a hormone produced in the hypothalamus and stored in the posterior pituitary gland. It plays a crucial role in regulating water balance and blood pressure in the body.
AVP acts on the kidneys to promote water reabsorption, which helps maintain adequate fluid volume and osmotic balance in the body. It also constricts blood vessels, increasing peripheral vascular resistance and thereby helping to maintain blood pressure. Additionally, AVP has been shown to have effects on cognitive function, mood regulation, and pain perception.
Deficiencies or excesses of AVP can lead to a range of medical conditions, including diabetes insipidus (characterized by excessive thirst and urination), hyponatremia (low sodium levels in the blood), and syndrome of inappropriate antidiuretic hormone secretion (SIADH).
Adrenergic alpha-1 receptor agonists are a type of medication that binds to and activates adrenergic alpha-1 receptors, which are found in various tissues throughout the body, including the smooth muscle of blood vessels, the heart, the liver, and the kidneys. When these receptors are activated, they cause a variety of physiological responses, such as vasoconstriction (constriction of blood vessels), increased heart rate and force of heart contractions, and relaxation of the detrusor muscle in the bladder.
Examples of adrenergic alpha-1 receptor agonists include phenylephrine, which is used to treat low blood pressure and nasal congestion, and midodrine, which is used to treat orthostatic hypotension (low blood pressure upon standing). These medications can have side effects such as increased heart rate, headache, and anxiety. It's important to use them under the supervision of a healthcare provider, as they may interact with other medications and medical conditions.
Laser-Doppler flowmetry (LDF) is a non-invasive, investigative technique used to measure microcirculatory blood flow in real time. It is based on the principle of the Doppler effect, which describes the change in frequency or wavelength of light or sound waves as they encounter a moving object or reflect off a moving surface.
In LDF, a low-power laser beam is directed at the skin or other transparent tissue. The light penetrates the tissue and scatters off the moving red blood cells within the microvasculature. As the light scatters, it undergoes a slight frequency shift due to the movement of the red blood cells. This frequency shift is then detected by a photodetector, which converts it into an electrical signal. The magnitude of this signal is directly proportional to the speed and concentration of the moving red blood cells, providing a measure of microcirculatory blood flow.
LDF has various clinical applications, including the assessment of skin perfusion in patients with peripheral arterial disease, burn injuries, and flaps used in reconstructive surgery. It can also be used to study the effects of drugs or other interventions on microcirculation in research settings.
Heart rate is the number of heartbeats per unit of time, often expressed as beats per minute (bpm). It can vary significantly depending on factors such as age, physical fitness, emotions, and overall health status. A resting heart rate between 60-100 bpm is generally considered normal for adults, but athletes and individuals with high levels of physical fitness may have a resting heart rate below 60 bpm due to their enhanced cardiovascular efficiency. Monitoring heart rate can provide valuable insights into an individual's health status, exercise intensity, and response to various treatments or interventions.
Adrenergic fibers are a type of nerve fiber that releases neurotransmitters known as catecholamines, such as norepinephrine (noradrenaline) and epinephrine (adrenaline). These neurotransmitters bind to adrenergic receptors in various target organs, including the heart, blood vessels, lungs, glands, and other tissues, and mediate the "fight or flight" response to stress.
Adrenergic fibers can be classified into two types based on their neurotransmitter content:
1. Noradrenergic fibers: These fibers release norepinephrine as their primary neurotransmitter and are widely distributed throughout the autonomic nervous system, including the sympathetic and some parasympathetic ganglia. They play a crucial role in regulating cardiovascular function, respiration, metabolism, and other physiological processes.
2. Adrenergic fibers with dual innervation: These fibers contain both norepinephrine and epinephrine as neurotransmitters and are primarily located in the adrenal medulla. They release epinephrine into the bloodstream, which acts on distant target organs to produce a more widespread and intense "fight or flight" response than norepinephrine alone.
Overall, adrenergic fibers play a critical role in maintaining homeostasis and responding to stress by modulating various physiological functions through the release of catecholamines.
Skin temperature is the measure of heat emitted by the skin, which can be an indicator of the body's core temperature. It is typically lower than the body's internal temperature and varies depending on factors such as environmental temperature, blood flow, and physical activity. Skin temperature is often used as a vital sign in medical settings and can be measured using various methods, including thermal scanners, digital thermometers, or mercury thermometers. Changes in skin temperature may also be associated with certain medical conditions, such as inflammation, infection, or nerve damage.
Blood vessels are the part of the circulatory system that transport blood throughout the body. They form a network of tubes that carry blood to and from the heart, lungs, and other organs. The main types of blood vessels are arteries, veins, and capillaries. Arteries carry oxygenated blood away from the heart to the rest of the body, while veins return deoxygenated blood back to the heart. Capillaries connect arteries and veins and facilitate the exchange of oxygen, nutrients, and waste materials between the blood and the body's tissues.
Phentolamine is a non-selective alpha-blocker drug, which means it blocks both alpha-1 and alpha-2 receptors. It works by relaxing the muscle around blood vessels, which increases blood flow and lowers blood pressure. Phentolamine is used medically for various purposes, including the treatment of high blood pressure, the diagnosis and treatment of pheochromocytoma (a tumor that releases hormones causing high blood pressure), and as an antidote to prevent severe hypertension caused by certain medications or substances. It may also be used in diagnostic tests to determine if a patient's blood pressure is reactive to drugs, and it can be used during some surgical procedures to help lower the risk of hypertensive crises.
Phentolamine is available in two forms: an injectable solution and oral tablets. The injectable form is typically administered by healthcare professionals in a clinical setting, while the oral tablets are less commonly used due to their short duration of action and potential for causing severe drops in blood pressure. As with any medication, phentolamine should be taken under the supervision of a healthcare provider, and patients should follow their doctor's instructions carefully to minimize the risk of side effects and ensure the drug's effectiveness.
Enzyme inhibitors are substances that bind to an enzyme and decrease its activity, preventing it from catalyzing a chemical reaction in the body. They can work by several mechanisms, including blocking the active site where the substrate binds, or binding to another site on the enzyme to change its shape and prevent substrate binding. Enzyme inhibitors are often used as drugs to treat various medical conditions, such as high blood pressure, abnormal heart rhythms, and bacterial infections. They can also be found naturally in some foods and plants, and can be used in research to understand enzyme function and regulation.
A kidney, in medical terms, is one of two bean-shaped organs located in the lower back region of the body. They are essential for maintaining homeostasis within the body by performing several crucial functions such as:
1. Regulation of water and electrolyte balance: Kidneys help regulate the amount of water and various electrolytes like sodium, potassium, and calcium in the bloodstream to maintain a stable internal environment.
2. Excretion of waste products: They filter waste products from the blood, including urea (a byproduct of protein metabolism), creatinine (a breakdown product of muscle tissue), and other harmful substances that result from normal cellular functions or external sources like medications and toxins.
3. Endocrine function: Kidneys produce several hormones with important roles in the body, such as erythropoietin (stimulates red blood cell production), renin (regulates blood pressure), and calcitriol (activated form of vitamin D that helps regulate calcium homeostasis).
4. pH balance regulation: Kidneys maintain the proper acid-base balance in the body by excreting either hydrogen ions or bicarbonate ions, depending on whether the blood is too acidic or too alkaline.
5. Blood pressure control: The kidneys play a significant role in regulating blood pressure through the renin-angiotensin-aldosterone system (RAAS), which constricts blood vessels and promotes sodium and water retention to increase blood volume and, consequently, blood pressure.
Anatomically, each kidney is approximately 10-12 cm long, 5-7 cm wide, and 3 cm thick, with a weight of about 120-170 grams. They are surrounded by a protective layer of fat and connected to the urinary system through the renal pelvis, ureters, bladder, and urethra.
Astringents are substances that cause the contraction of body tissues, particularly the skin and mucous membranes. They have the ability to shrink or constrict proteins in the skin or mucous membrane, leading to a tightening effect. This is often used in various medical and cosmetic applications.
In a medical context, astringents are often used to:
1. Dry up weeping or oozing wounds or sores.
2. Reduce local inflammation.
3. Control bleeding from minor cuts or wounds by constricting the blood vessels.
Commonly used astringent substances include tannins, found in plants like oak bark and witch hazel, as well as aluminum salts, found in some antiperspirants. Astringents are often applied topically in the form of lotions, gels, or solutions. However, they can also be used systemically, although this is less common.
It's important to note that while astringents have therapeutic uses, they can also cause skin irritation and dryness if not used properly. Therefore, it's recommended to follow the instructions provided by a healthcare professional or as directed on the product label.
Bretylium compounds are a class of medications that are primarily used in the management of life-threatening cardiac arrhythmias (abnormal heart rhythms). Bretylium tosylate is the most commonly used formulation. It works by stabilizing the membranes of certain types of heart cells, which can help to prevent or stop ventricular fibrillation and other dangerous arrhythmias.
Bretylium compounds are typically administered intravenously in a hospital setting under close medical supervision. They may be used in conjunction with other medications and treatments for the management of cardiac emergencies. It's important to note that bretylium compounds have a narrow therapeutic index, which means that the difference between an effective dose and a toxic one is relatively small. Therefore, they should only be administered by healthcare professionals who are experienced in their use.
Like all medications, bretylium compounds can cause side effects, including but not limited to:
- Increased heart rate
- Low blood pressure
- Nausea and vomiting
- Dizziness or lightheadedness
- Headache
- Tremors or muscle twitching
- Changes in mental status or behavior
Healthcare providers will monitor patients closely for any signs of adverse reactions while they are receiving bretylium compounds.
Postganglionic sympathetic fibers are the portion of the sympathetic nervous system's nerve fibers that originate from the cell bodies located in the ganglia ( clusters of neurons) outside the spinal cord. After leaving the ganglia, these postganglionic fibers travel to and innervate target organs such as sweat glands, blood vessels, and various smooth muscles, releasing neurotransmitters like norepinephrine and neuropeptide Y to regulate physiological functions. Acetylcholine is the neurotransmitter released by postganglionic fibers that innervate sweat glands.
Nitro-L-arginine or Nitroarginine is not a medical term per se, but it is a chemical compound that is sometimes used in medical research and experiments. It is a salt of nitric acid and L-arginine, an amino acid that is important for the functioning of the body.
Nitroarginine is known to inhibit the production of nitric oxide, a molecule that plays a role in various physiological processes such as blood flow regulation, immune response, and neurotransmission. As a result, nitroarginine has been used in research to study the effects of reduced nitric oxide levels on different systems in the body.
It's worth noting that nitroarginine is not approved for use as a medication in humans, and its use is generally limited to laboratory settings.
Local anesthetic
Vasoconstriction
Ornipressin
Blood vessel
Thromboxane
Dental anesthesia
Tuaminoheptane
Von Willebrand disease
Pulpotomy
Cocaine
Periradicular surgery
Hemorrhoid
Yohimbine
Dopamine (medication)
Norpropylhexedrine
Reflex syncope
Impedance cardiography
Mephedrone
Antihypotensive agent
Propylhexedrine
Paracentesis
Medication
Vittorio Erspamer
Serotonin
Furosemide
Phentolamine
Melatonin
Angiotensin-converting enzyme
Cyclopentamine
Inotrope
Congenital Hepatic Fibrosis Medication: Antibiotics, Choleretic agents, Vasoconstrictors
Pressonex - Adrenergic Agents, Adrenergic alpha-Agonists, Sympathomimetics, Vasoconstrictor Agents, ATC...
Zip - Vasoconstrictor Agents, Anesthetics, Local Anesthetics, ATC:N01BC01, ATC:R02AD03, ATC:S01HA01, ATC...
R)-noradrenaline (CHEBI:18357)
Methylene Blue Monotherapy Compared With Combination Therapy With Hydroxocobalamin for the Treatment of Refractory Vasoplegic...
Local anesthetic - Wikipedia
Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1)
Free Dentistry Flashcards about Pain Control
Distributive Shock: Practice Essentials, Pathophysiology, Etiology
Singh, Sonal | Profiles RNS
Dental anesthesia: Overview of injectable agents useful for nonsurgical periodontal therapy | Registered Dental Hygienists
Infraorbital Nerve Block: Overview, Indications, Contraindications
Hyperventilation - Managing Adult Medical Emergencies in the Dental Office - Dentalcare
Anesthesia in Hair Transplantation | IntechOpen
Catecholamines | DrugBank Online
Infraorbital Nerve Block: Overview, Indications, Contraindications
Handbook of Local Anesthesia Elsevier eBook on Vitalsource (Retail Access Card), 7th Edition - 9780323613446
Early vasopressor use following traumatic injury: a systematic review - McMaster Experts
Dental Hygiene Degree | Catalog: Harper College
Buy Sansert (Methysergide Maleate) 1mg Online Cheap - North Drugstore
HEMODINAMIC MONITORING IN TRAUMA
Lidocaine Hydrochloride Injection, USP Preservative free-lidocaine hydrochloride injection solution Spectra...
These highlights do not include all the information needed to use Zorcaine® safely and effectively. See full prescribing...
Thieme E-Journals - Digestive Disease Interventions / Abstract
Vasopressin in perioperative management of congenital diaphragmatic hernia: A case report<...
The Authors' reply | Gut
NIOSHTIC-2 Search Results - Full View
The endothelial glycocalyx : moderator of platelet-vessel wall interactions in atherogenesis?<...
MeSH Browser
Antihistamine-vasoconstrictor1
- Ophthalmic anti-allergic treatment includes topical mast cell stabilizers, oral and topical antihistamines, antihistamine-vasoconstrictor combinations, dual action agents with mast cell-stabilizing, and antihistaminic properties, and anti-inflammatory agents including steroids and non-steroidal drugs. (frontiersin.org)
Potent vasoconstrictor2
- We summarize the role of endothelin as a potent vasoconstrictor, pro-inflammatory, pro-oxidative agent in the pathophysiologic effects and end-organ dysfunction of coronavirus disease 2019 (COVID-19). (elsevierpure.com)
- This, in turn, inhibits the conversion of arachidonic acid to prostaglandin 12 (a potent vasodilator and inhibitor of platelet activation) and thromboxane A2 (a potent vasoconstrictor and platelet aggregate). (medscape.com)
Vasodilator1
- The endothelium modulates vascular tone by the release of vasodilator and vasoconstrictor substances, among them nitric oxide (NO) and endothelin (ET). (elsevierpure.com)
Receptors1
- Topical vasoconstrictors act on alpha-adrenergic receptors in the nasal mucosa, causing vessels to constrict. (medscape.com)
Diuretics1
- Loop diuretics such as furosemide and bumetanide are first line, with aldosterone antagonists sometimes considered as adjunctive agents. (medscape.com)
Endothelin1
- Endothelin-1 (ET-1) is a potent endothelium-derived vasoconstrictor that might aggravate reperfusion injury. (uni-luebeck.de)
Nitric Oxide1
- We also hypothesized that nitric oxide (NO) blunts cerebral vasoconstrictor responses to NE. (birmingham.ac.uk)
Cerebral Arteries1
- We hypothesized that the density of sympathetic noradrenergic innervation of cerebral arteries and vasoconstrictor responses evoked in carotid circulation by norepinephrine (NE) increase with maturation and age. (birmingham.ac.uk)
Therapeutic2
- Acute pancreatitis is still a life-threatening disease without an evidenced therapeutic agent. (bvsalud.org)
- A chymase inhibitor may become a novel therapeutic agent for acute pancreatitis. (bvsalud.org)
SUMATRIPTAN1
- Sumatriptan appeared to have a vasoconstrictor effect on the relaxed vessels by CO 2 inhalation. (elsevierpure.com)
Serotonin1
- Serotonin has been variously described as a central neurohumoral agent or chemical mediator, as a "headache substance" acting directly or indirectly to lower pain threshold, as an intrinsic "motor hormone" of the gastrointestinal tract, and as a "hormone" involved in connective tissue reparative processes. (pharmacycode.com)
Nasal1
- In essence, a nasal decongestant is a vasoconstrictor (blood vessel shrinking agent). (internationaldrugmart.com)
Drugs3
- What are vasoconstrictors: Vasopressin, norepinephrine, and dopamine are commonly used drugs required to maintain blood pressure in ICU patients who have septic shock which is low blood pressure caused by sepsis. (thepearldream.com)
- LA drugs are also often combined with other agents such as opioids for synergistic analgesic action. (wikipedia.org)
- Dopamine and dobutamine are the drugs of choice to improve cardiac contractility, with dopamine the preferred agent in patients with hypotension. (medscape.com)
Endothelium1
- Many environmental agents increase the permeability of the capillary endothelium and/or respiratory epithelium and induce pulmonary edema. (nih.gov)
Dopamine1
- Dopamine administered intravenously is a myocardial inotropic agent, which also may increase mesenteric and renal blood flow plus urinary output. (nih.gov)
Anesthetic10
- When anesthetics are used concomitantly with vasoconstrictors, their anesthetic effect is prolonged and the pain threshold increased. (medscape.com)
- They are used in various techniques of local anesthesia such as: Topical anesthesia (surface anesthesia) Topical administration of cream, gel, ointment, liquid, or spray of anesthetic dissolved in DMSO or other solvents/carriers for deeper absorption Infiltration Brachial plexus block Epidural block (extradural) Spinal anesthesia (subarachnoid block) Iontophoresis Diagnostic purposes (e.g. dibucaine) Anti-arrhythmic agents (e.g. lidocaine). (wikipedia.org)
- Most local anesthetic agents share the same basic chemical structure, which consists of an aromatic ring, linked to an intermediate chain, linked to a hydrophilic amine segment. (medscape.com)
- An infraorbital nerve block requires 1-3 mL of the chosen anesthetic agent. (medscape.com)
- Bupivacaine (Marcaine) is another frequently used anesthetic agent. (medscape.com)
- For more information, see Local Anesthetic Agents, Infiltrative Administration . (medscape.com)
- Articadent (articaine HCl and epinephrine ) is an amide local anesthetic containing a vasoconstrictor indicated for local, infiltrative, or conductive anesthesia in both simple and complex dental procedures. (rxlist.com)
- Xylocaine (lidocaine HCl) Injections are sterile, nonpyrogenic, aqueous solutions that contain a local anesthetic agent with or without epinephrine and are administered parenterally by injection. (drugs.com)
- With central neural blockade these changes may be attributable to block of autonomic fibers, a direct depressant effect of the local anesthetic agent on various components of the cardiovascular system, and/or the beta-adrenergic receptor stimulating action of epinephrine when present. (drugs.com)
- This CE webinar will review the current local anesthetic agents available for use and discuss indications for the various agents. (vivalearning.com)
Intracellular1
- This agent causes relaxation of vascular smooth muscle by stimulating intracellular cyclic guanosine monophosphate production. (medscape.com)
Topical1
- An oral antihistamine may be used in conjunction with topical agents. (uspharmacist.com)
Articaine1
- Epinephrine bitartrate, (-)-1-(3,4-Dihydroxyphenyl)-2-methylamino-ethanol (+) tartrate (1:1) salt, is a vasoconstrictor that is added to articaine HCI in a concentration of 1:200,000 or 1:100,000 (expressed as free base). (rxlist.com)
Responses1
- The three peptides produce vasoconstrictor and pressor responses in various parts of the body. (lookformedical.com)
Receptor1
- Para inhibir el efecto vasoconstrictor e hipertensivo de la angiotensina II, a menudo se trata a los pacientes con INHIBIDORES DE LA ECA o con BLOQUEANTES DEL RECEPTOR DE TIPO 1 DE LA ANGIOTENSINA II. (bvsalud.org)
Amide1
- The chemical structure of this intermediate group classifies the agent into the amide group or the ester group. (medscape.com)
Amino1
- 21-Amino-acid peptides produced by vascular endothelial cells and functioning as potent vasoconstrictors. (lookformedical.com)
Induce1
- We conclude that environmental agents induce changes in epithelial function that may compromise the lung's ability to regulate respiratory fluid without destroying the characteristic permeability of the epithelial lining. (nih.gov)
Shock1
- These agents augment coronary and cerebral blood flow during the low-flow state associated with cardiogenic shock. (medscape.com)
Anesthesia1
- Vasoconstrictor agents for local anesthesia. (bvsalud.org)
Pharmacologic agents2
- There are several pharmacologic agents for the treatment of AC. (uspharmacist.com)
- Application of pharmacologic agents, e.g. amphotericin, ouabain, onto the respiratory epithelium induces similar changes in in vitro and in vivo PD. (nih.gov)
Antiretroviral agents2
- This report includes the guidelines developed by the Panel regarding the use of laboratory testing in initiating and managing antiretroviral therapy, considerations for initiating therapy, whom to treat, what regimen of antiretroviral agents to use, when to change the antiretroviral regimen, treatment of the acutely HIV-infected person, special considerations in adolescents, and special considerations in pregnant women. (cdc.gov)
- The guidelines contain recommendations for the clinical use of antiretroviral agents in the treatment of adults and adolescents (defined in Considerations for Antiretroviral Therapy in the HIV-Infected Adolescent) who are infected with the human immunodeficiency virus (HIV). (cdc.gov)
HYPOTENSION1
- It is used as a vasoconstrictor agent in the treatment of HYPOTENSION. (umassmed.edu)
Cardiac1
- To assess this recommendation a patient with Eisenmenger's syndrome was administered the vasoconstrictor drug phenylephrine during diagnostic cardiac catheterisation. (edu.au)
Injection1
- Used for Endoscopic injection to introduce a sclerosing agent of vasoconstrictor into selected sites to control actual or potential bleeding lesions. (shailiendoscopy.com)
Blood1
- Rosa adds that since many numbing agents have vasoconstrictors , which constrict blood vessels, the skin can become rubbery. (elitedaily.com)
Allergic1
- This structural difference determines the pathway by which the agent is metabolized and its allergic potential. (medscape.com)
Treatment3
- for appropriate treatment, it is important that the etiologic agent be identified. (uspharmacist.com)
- On this basis a peripheral vasoconstrictor drug has frequently been recommended as an appropriate form of treatment. (edu.au)
- These agents have a potential role against COVID-19 and should be studied in research trials to determine their efficacy in treatment of this severe disease. (elsevierpure.com)
Drug1
- The result provides a caution about the advisability of administering a vasoconstrictor drug to an Eisenmenger patient. (edu.au)
Commonly1
- Lidocaine (Xylocaine) is the most commonly used agent. (medscape.com)
Action1
- We conclude that techniques that have been used to measure permeability and transport in other epithelia may help elucidate modes of action of environmental agents on airways. (nih.gov)
Lidocaine1
- Information derived from diverse formulations, concentrations and usages reveals that lidocaine HCl is completely absorbed following parenteral administration, its rate of absorption depending, for example, upon various factors such as the site of administration and the presence or absence of a vasoconstrictor agent. (drugs.com)
HYPERTENSION1
- These agents are used in medical management of portal hypertension. (medscape.com)
Administration3
- Vasoconstrictor agent administration raised the risk of pressure injuries in critical care patients by nearly twofold. (thepearldream.com)
- SANTA BARBARA, CA, UNITED STATES, September 20, 2023 / EINPresswire.com / - "Vasoconstrictor agent administration raised the risk of pressure injuries in critical care patients by nearly twofold. (thepearldream.com)
- More emphasis should be placed on the timely prevention of pressure injuries in patients receiving vasoconstrictor agent administration in the ICU"…Advances in Wound Care, 27, July 2023. (thepearldream.com)
Patient1
- Although there are multiple agents available a rationale approach to choices based on procedures, patient ages and medical interactions will be reviewed. (vivalearning.com)
Powerful2
- Prevalence rates standardized (x 100,000Powerful binding agent and vasoconstrictor.erec-type 1, and assess the indicators in subjects with previous. (bahamasuncensored.com)
- Powerful binding agent and vasoconstrictor. (healthywealthytribe.com)
Good1
- It is a potent anti-inflammation agent and good vasoconstrictor. (healthynet.eu)